Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201107208 Principal Investigator: Bartlett, Nancy
Title: An Open-Label, Single-arm, Phase I study of AEB071 (a Protein Kinase C Inhibitor) in Patients with CD79-mutant Diffuse Large B-Cell Lymphoma
Phase: I Disease Site: Non-Hodgkin's Lymphoma
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purpose of this clinical research study is to test if the study drug AEB071 has any activity against a certain type of Diffuse Large B-Cell Lymphoma. It also will help to determine the highest dose of AEB071 that can be given safely without unacceptable side effects. The study will also examine how much and for how long AEB071 stays in patients' blood.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)